Skip to Content
Discovering the causes of cancer and the means of prevention

Principal Investigators

Show Links to Display Other Staff Show only specific programs/branches (click + or - to show/hide)

HUMAN GENETICS PROGRAM (HGP)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

  • Achatz, Maria Isabel, M.D., Ph.D.
    Cancer genetics, inherited cancer predisposition syndromes; Clinical, Molecular and epidemiological characterization on Li-Fraumeni syndrome and Xeroderma Pigmentosum
  • Alter, Blanche P., M.D., M.P.H.
    Study of inherited bone marrow failure syndromes. Using Fanconi's anemia as the prototype for an interdisciplinary approach to elucidate the mechanisms of carcinogenesis in humans.
  • Amundadottir, Laufey, Ph.D.
    gene mapping, functional analyses, pancreatic cancer,

B

  • Brown, Kevin, Ph.D.
    Melanoma, genome-wide association studies, familial linkage studies, RNAi, cancer therapeutics.

C

  • Chaturvedi, Anil K., Ph.D.
    Role of HPV in the etiology of head and neck cancers, natural history of head and neck cancer precursors, inflammation and cancer risk, role of inflammation in the etiology of lung cancer and other smoking-associated cancers.

G

  • Gadalla, Shahinaz, Ph.D., M.B.Bch.
    Dr. Gadalla’s research interests focus on the role of genetic factors in cancer etiology, as well as identifying genetic and environmental risk factors among individuals at high risk of developing cancer.
  • Goldstein, Alisa M., Ph.D.
    Genetic epidemiology of cancer, integrating epidemiologic, clinical, and molecular approaches. Developing and evaluating methods to examine gene-environment interactions in complex diseases.
  • Greene, Mark H., M.D.
    Familial/hereditary cancers, genetic determinants of outcomes following cancer treatment, as well as intervention studies (cancer screening, surgical risk reduction and chemoprevention) in genetically at-risk populations, genetic modifiers of cancer risk, and leveraging alert clinical observations into novel etiologic insights.

L

  • Landi, Maria T., M.D., Ph.D.
    Association and linkage approaches in genetic epidemiology of cutaneous malignant melanoma, genetic factors of lung cancer and smoking, health consequences of dioxin exposure.

M

S

  • Savage, Sharon A., M.D.
    Genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes.
  • Schiffman, Mark, M.D., M.P.H.
    Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
  • Stewart, Douglas, M.D.
    Cancer risk and phenotype in the DICER1 syndrome and neurofibromatosis type 1. Gene identification in familial tumor-predisposition disorders.

T

  • Tucker, Margaret A., M.D.
    Studies of predictors of high cancer risk among populations with specific genetic alterations or families with high rate of cancers. Integration of clinical, epidemiologic, and molecular research.

W

  • Wentzensen, Nicolas, M.D., Ph.D.
    Etiology of cervical, ovarian, and endometrial cancer. HPV - related carcinogenesis. Discovery and translation of biomarkers for gynecological cancers. Gene methylation.

Y

  • Yang, Rose, Ph.D., M.P.H.
    Genetics of familial cutaneous malignant melanoma/dysplastic nevi syndrome and chordoma, and etiologic heterogeneity of breast cancer.